MarketGrader Developed Markets (ex-Australia) Health Care Index


Five Largest Companies
Symbol Name Grade Market Cap Country
LLY Eli Lilly and Company 77.0 ¤1,034,568 US
JNJ Johnson & Johnson 51.6 ¤549,785 US
MRK Merck & Co., Inc. 54.7 ¤281,238 US
AZN.GB AstraZeneca PLC 59.6 ¤269,316 GB
NOVO.B.DK Novo Nordisk A/S Class B 76.8 ¤190,831 DK

Five Smallest Companies
Symbol Name Grade Market Cap Country
326030.KR SK Biopharmaceuticals Co., Ltd. 79.9 ¤4,517 KR
YPSN.CH Ypsomed Holding AG 70.4 ¤5,405 CH
4151.JP Kyowa Kirin Co., Ltd. 66.6 ¤8,130 JP
HALO Halozyme Therapeutics, Inc. 73.6 ¤8,131 US
UHS Universal Health Services, Inc. Class B 67.5 ¤8,546 US

Companies with Most Selections Among Current Components
Symbol Name Grade Times* Country
NOVO.B.DK Novo Nordisk A/S Class B 76.8 38 DK
AMGN Amgen Inc. 62.2 31 US
ISRG Intuitive Surgical, Inc. 72.6 27 US
RMD ResMed Inc. 68.1 25 US
JNJ Johnson & Johnson 51.6 24 US
LLY Eli Lilly and Company 77.0 23 US
4507.JP Shionogi & Co., Ltd. 71.2 22 JP
BMY Bristol-Myers Squibb Company 61.9 22 US
4519.JP Chugai Pharmaceutical Co., Ltd. 66.0 21 JP
7741.JP HOYA CORPORATION 67.8 21 JP
*Number of times selected at Index semi-annual reconstitutions since inception date.
Index Bio
Average Market Cap ¤81,092
Median Market Cap ¤24,500
Avg. 3 Mo. Dollar Vol. ¤355,153,487
Avg. 3 Mo. Trading Vol. 2,717,323
Last Rebalance Date 03/23/2026
Companies Replaced 11
Biggest Industry Increase Medical Specialties
Biggest Industry Decrease Pharmaceuticals: Major

Fundamental Attributes
Trailing P/E Ratio (12 Mo.) 24.3
Forward P/E Ratio (12 Mo.) 18.1
Price/Book Ratio 6.1
Avg. Revenue Chg. - 3 Yr 40.9%
Avg. Op. Income Chg. - 3 Yr. 92.0%
Avg. EPS Growth - 3 Yr. 25.3%
Avg. EPS Growth - 1 Yr. 16.7%
Avg. Operating Margin 25.9%
Avg. LT Debt to Total Capital 25.9%
Avg. Return on Equity 23.0%
Dividend Yield 0.4%
Index Average Grade
Developed Markets (ex-Australia) Health Care Index 67.55
Country Breakdown
United States Of America 58.0%
Japan 14.0%
Korea, Republic Of 6.0%
Denmark 4.0%
United Kingdom 4.0%
Israel 2.0%
Finland 2.0%
France 2.0%
Belgium 2.0%
Switzerland 2.0%
Netherlands 2.0%
New Zealand 2.0%
For more information on this index please contact us

Get Access to the World's Smartest Global Research Platform

Don't wait another day to make better informed, higher-returning investments.

TRY IT FOR FREE